The House Ways and Means Committee on Tuesday approved the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113), AHA-supported legislation that would increase transparency with regard to prescription drug pricing. 
  
"As it considers this legislation, we want to commend the Committee for including several policies that will better hold drug manufacturers accountable," AHA said in a letter of support for the bill. 
  
Specifically, AHA applauded the inclusion of the Reporting Accurate Drug Prices Act, which would require all manufacturers to submit pricing data to the Department of Health and Human Services; and the SPIKE Act, which would require drug companies to provide written justification for new drugs with high launch prices or existing drugs with excessive price increases over certain time periods. AHA also voiced support for provisions that would make publicly available the total amount and value of the free samples drug manufacturers provide to patients. 
  
"While the AHA understands the assistance that free drug samples can provide for patients who need them, especially those individuals with limited financial flexibility, we are concerned that these samples may improperly incentivize patients and providers to use and prescribe certain drugs," the association said.

Related News Articles

Headline
The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption…
Headline
The AHA today voiced support for the Improving Seniors’ Timely Access to Care Act (H.R. 3107), bipartisan legislation that would establish requirements for the…
Headline
The House of Representatives today passed and sent to the President a Medicaid-related bill (H.R. 3253) that includes a provision extending the Certified…
Headline
Medicaid disproportionate share hospital payments to eligible hospitals covered 51% of their uncompensated care costs in 2014, the most recently available…
Headline
The House of Representatives today passed 284-149 a two-year budget agreement (H.R. 3877) that increases discretionary funding limits and suspends the debt…
Headline
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., today released a description of the chairman’s mark, the…